Suheung Co., Ltd.

Research Suheung Co., Ltd. (008490.KS) on Bullrun: market cap KRW 199.34B, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 199.34B; dividend yield is 2.8%.

Peer valuation comparison

Latest dividend yield is 2.83% versus a Healthcare sector median of 2.4% (17.9% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-11-10KRW 199.34Bn/a2.8%500

Dividend history

Latest trailing dividend snapshot: annual dividend/share 500 KRW, yield 2.8%.

About Suheung Co., Ltd.

Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver-treatment medicine, and nutritional supplements;

ETFs that hold Suheung Co., Ltd.

US-listed ETFs

Suheung Co., Ltd. is held by 5 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:

ETFWeightFee
Dimensional Emerging Core Equity Market ETF (DFAE)<0.01%0.29%
Dimensional Emerging Markets Core Equity 2 ETF (DFEM)<0.01%0.39%
Dimensional World ex U.S. Core Equity 2 ETF (DFAX)<0.01%0.28%
Dimensional Emerging Markets Value ETF (DFEV)<0.01%0.43%
Dimensional Emerging Markets ex China Core Equity ETF (DEXC)<0.01%0.43%

Portfolios as filed with the SEC on Form N-PORT, dated July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Suheung Co., Ltd.'s market cap?

Suheung Co., Ltd.'s market capitalization is KRW 199.34B.

Does Suheung Co., Ltd. pay a dividend?

Suheung Co., Ltd. has a dividend yield of 2.8%.

What does Suheung Co., Ltd. do?

Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver-treatment medicine, and nutritional supplements; and quasi-drugs, which includes low-content vitamin-cosmetic products, multi-vitamin, toothpaste, effervescent tablet, and chewable tablet.